Zucara Therapeutics
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$84—126m (Dealroom.co estimates Mar 2020.)
Electoral Area A British Columbia (HQ)
Authorizing premium user...